Clincosm LogoSign in Get a demo

infections, bacterial

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS) Trial in London (Salmonella Typhimurium)

Not yet recruiting
  • Salmonella Infections
  • +7 more
  • Salmonella Typhimurium
  • London, England, United Kingdom
    Imperial College London
May 11, 2023

TAAI Erasmus Research Initiative to Fight CF: Monitoring

Recruiting
  • Cystic Fibrosis
  • +9 more
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC - Sophia Children's Hospital
    Feb 21, 2023

    Infections, Bacterial Trial (Augmentin ES)

    Not yet recruiting
    • Infections, Bacterial
    • Augmentin ES
    • (no location specified)
    Jul 15, 2022

    Infections, Bacterial Trial in Las Vegas (Gepotidacin, Cimetidine, Rifampicin)

    Completed
    Has Results
    • Infections, Bacterial
    • Las Vegas, Nevada
      GSK Investigational Site
    Dec 9, 2021

    Infections, Bacterial Trial in Edgewater, Overland Park, Knoxville (AVA, Raxibacumab, Diphenhydramine)

    Completed
    Has Results
    • Infections, Bacterial
    • AVA
    • +2 more
    • Edgewater, Florida
    • +2 more
    Jul 13, 2021

    Infections, Bacterial Trial in Miami, Orlando (Gepotidacin)

    Completed
    Has Results
    • Infections, Bacterial
    • Miami, Florida
    • +1 more
    Mar 17, 2021

    Infections, Bacterial, Sepsis, Alert Fatigue, Health Personnel Trial in Boston (Epic Best Practice Alert)

    Unknown status
    • Infections, Bacterial
    • +2 more
    • Epic Best Practice Alert
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 3, 2020

    Infections, Bacterial Trial in Anaheim, Austin (Gepotidacin RC Tablet, Gepotidacin HSWG Tablet, Gepotidacin Capsule)

    Completed
    Has Results
    • Infections, Bacterial
    • Gepotidacin RC Tablet
    • +2 more
    • Anaheim, California
    • +1 more
    Sep 14, 2020

    Infections, Bacterial Trial (Collection of samples)

    Not yet recruiting
    • Infections, Bacterial
    • Collection of samples
    • (no location specified)
    Oct 1, 2020

    Infections, Bacterial Trial in Las Vegas (Gepotidacin, Placebo)

    Completed
    Has Results
    • Infections, Bacterial
    • Las Vegas, Nevada
      GSK Investigational Site
    Aug 18, 2020

    Infections, Bacterial Trial in Miami, Orlando, Minneapolis (Gepotidacin)

    Completed
    Has Results
    • Infections, Bacterial
    • Miami, Florida
    • +2 more
    Jul 13, 2020

    Infections, Bacterial Trial in La Mesa (Gepotidacin)

    Completed
    Has Results
    • Infections, Bacterial
    • La Mesa, California
      GSK Investigational Site
    Jun 12, 2020

    Gram-negative Bacilli and MRSA Screening in ICU in China

    Unknown status
    • Infections, Bacterial
    • None intervention. This is an observational study.
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital
    Mar 18, 2020

    Infections, Bacterial Trial in Bloemfontein (Test formulation A, Reference formulation B)

    Completed
    Has Results
    • Infections, Bacterial
    • Test formulation A
    • Reference formulation B
    • Bloemfontein, Free State, South Africa
      GSK Investigational Site
    Feb 17, 2020

    Infections, Bacterial Trial in Overland Park (GSK1322322 Initial fit for purpose tablets, GSK1322322 over granulated tablets,

    Terminated
    • Infections, Bacterial
    • GSK1322322 Initial fit for purpose tablets
    • +6 more
    • Overland Park, Kansas
      GSK Investigational Site
    Jan 11, 2019

    Infections, Bacterial Trial in Bloemfontein, (GR37547 tablet, Ciprofloxacin reference tablet)

    Completed
    Has Results
    • Infections, Bacterial
    • GR37547 tablet
    • Ciprofloxacin reference tablet
    • Bloemfontein,, South Africa
      GSK Investigational Site
    Jun 27, 2018

    Infections, Bacterial Trial in Adelaide (GSK3342830, Placebo)

    Terminated
    Has Results
    • Infections, Bacterial
    • Adelaide, South Australia, Australia
      GSK Investigational Site
    Sep 11, 2018

    Infections, Bacterial Trial in Goiania (Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL, Amoxil® 500mg/5mL powder

    Completed
    Has Results
    • Infections, Bacterial
    • Amoxicillin powder for oral suspension (Clamoxyl®) 500mg/5mL
    • Amoxil® 500mg/5mL powder for oral suspension
    • Goiania, Goiás, Brazil
      GSK Investigational Site
    Jun 18, 2018

    Infections, Bacterial Trial (Cefixime test capsule, Cefixime reference capsule)

    Withdrawn
    • Infections, Bacterial
    • Cefixime test capsule
    • Cefixime reference capsule
    • (no location specified)
    Mar 5, 2018

    Infections, Bacterial Trial in United States (GSK2140944 Lyophile, GSK2140944 Capsules)

    Completed
    Has Results
    • Infections, Bacterial
    • GSK2140944 Lyophile
    • GSK2140944 Capsules
    • Phoenix, Arizona
    • +29 more
    Oct 16, 2017

    An Electronic Questionnaire In Chronic Obstructive Pulmonary

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Infections, Bacterial
    • GSK questionnaire
    • +3 more
    • Birmingham, Alabama
    • +122 more
    Oct 10, 2017

    Infections, Bacterial Trial in Greifswald (flucloxacillin 250 mg, flucloxacillin 500 mg)

    Completed
    • Infections, Bacterial
    • flucloxacillin 250 mg
    • flucloxacillin 500 mg
    • Greifswald, Mecklenburg-Vorpommern, Germany
      GSK Investigational Site
    Sep 27, 2017

    Thermal Imaging of Lung onSmartphone to Differentiate Bacterial

    Completed
    • Pneumonia, Bacterial
    • Infections, Bacterial
    • Thermal imaging of infant's chest with a mobile phone
    • Blantyre, Malawi
      Queen Elizabeth Central Hospital
    Sep 5, 2017

    Infections, Bacterial Trial in Overland Park (GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule)

    Completed
    • Infections, Bacterial
    • GSK2140944 capsule
    • +2 more
    • Overland Park, Kansas
      GSK Investigational Site
    Jul 10, 2017

    Infections, Bacterial Trial in Adelaide (GSK2251052, Placebo)

    Completed
    • Infections, Bacterial
    • Adelaide, South Australia, Australia
      GSK Investigational Site
    Jun 27, 2017